Business Wire05.20.19
Bio-Rad Laboratories Inc., a global provider of life science research and clinical diagnostic products, has appointed Ilan Daskal as executive vice president and chief financial officer (CFO).
Daskal comes to Bio-Rad from Lumileds, where he served as CFO. He has over 25 years of experience in senior financial roles and has held several CFO positions at both public and private companies that include International Rectifier Corporation and Infineon.
Daskal earned a masters degree in finance degree from City University of New York and a BB in accounting from Tel-Aviv College of Business in Israel.
“Ilan brings a breadth of experience in finance, operations, IT, as well as mergers and acquisitions, all in a global setting," said Norman Schwartz, Bio-Rad president and CEO. "We believe he will make an excellent addition to Bio-Rad."
Bio-Rad Laboratories Inc. develops, manufactures, and markets a broad range of products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, its products advance the discovery process and improve healthcare. The company's customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, Calif., and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018.
Daskal comes to Bio-Rad from Lumileds, where he served as CFO. He has over 25 years of experience in senior financial roles and has held several CFO positions at both public and private companies that include International Rectifier Corporation and Infineon.
Daskal earned a masters degree in finance degree from City University of New York and a BB in accounting from Tel-Aviv College of Business in Israel.
“Ilan brings a breadth of experience in finance, operations, IT, as well as mergers and acquisitions, all in a global setting," said Norman Schwartz, Bio-Rad president and CEO. "We believe he will make an excellent addition to Bio-Rad."
Bio-Rad Laboratories Inc. develops, manufactures, and markets a broad range of products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, its products advance the discovery process and improve healthcare. The company's customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, Calif., and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018.
